BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 5, 2012
View Archived Issues
Stem cell gene therapy improves erectile dysfunction in rats
Read More
Novel HCV candidate identified by group in Taiwan
Read More
Roche Glycart patents novel IL-2 immunoconjugates
Read More
Russian group prepares new monoclonal antibodies
Read More
Plexxikon discloses novel protein kinase inhibitors
Read More
A novel pan-JAK inhibitor shows promise for adjuvant-induced arthritis
Read More
Indiana University researchers divulge new peptide phospholipid conjugates
Read More
Teduglutide receives European marketing authorization for short bowel syndrome
Read More
Novel antibacterial agents presented by Daiichi Sankyo
Read More
BioLineRx and Biokine Therapeutics enter licensing agreement for hematological cancers
Read More
Enrollment completed in phase III ATX-101 trial for submental fat
Read More
GlaxoSmithKline identifies novel DNA gyrase inhibitors for the treatment of tuberculosis
Read More
First patient enrolled in phase II AVP-923 trial in Alzheimer's disease
Read More
Sarepta Therapeutics receives U.S. government funding for Marburg virus therapy
Read More
Zalicus begins first of two phase IIa Z-160 studies in neuropathic pain
Read More
ImmusanT begins Nexvax-2 trials in celiac disease
Read More
AlloCure begins phase II study in acute kidney injury
Read More
BioSante Pharmaceuticals reports phase III safety data for LibiGel
Read More
Myrexis returns compounds to EpiCept
Read More
Relmada Therapeutics devises extended-release delivery systems for REL-1041
Read More
Baxter submits BLA to FDA seeking approval of hemophilia B drug
Read More
NIDA to fund phase II methamphetamine addiction trial of MN-166
Read More
GSK-961081 demonstrates efficacy as a bronchodilator in a phase II study
Read More
FDA approves Pfizer's bosutinib for CML
Read More
Medivir acquires preclinical antiviral programs from Novadex
Read More
New funding supports Cellerant's development of CLT-008
Read More
Dainippon Sumitomo Pharma seeks Chinese approval for amrubicin for SCLC
Read More